Title : Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine.

Pub. Date : 2011 Dec

PMID : 21925266






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Isradipine is a Federal Drug Administration-approved dihydropyridine calcium channel blocker that binds selectively to Ca(v)1.2 in the hippocampus. Isradipine immunoglobulin lambda variable 2-8 Homo sapiens
2 Our studies have shown that isradipine in vitro attenuates beta amyloid oligomer toxicity by suppressing calcium influx into cytoplasm and by suppressing Ca(v)1.2 expression. Isradipine immunoglobulin lambda variable 2-8 Homo sapiens
3 This review highlights the importance of Ca(v)1.2 channel overexpression, the accumulation of hyperphosphorylated tau and suppression of autophagy in Alzheimer"s disease and modulation of this pathway by isradipine. Isradipine immunoglobulin lambda variable 2-8 Homo sapiens